Home › Asset managers › Blackstone Alternative Investment Funds › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Blackstone Alternative Investment Funds voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
1,354 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Blackstone Alternative Investment Funds voted | Funds |
|---|---|---|---|---|---|---|
| 10x Genomics, Inc. | 2026-06-04 | Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Serge Saxonov | Director Elections | Board | AGAINST | 1 |
| 180 Life Sciences Corp. | 2025-07-24 | Approval of the adoption of the 180 Life Sciences Corp. 2025 Option Incentive Plan | Compensation | Board | AGAINST | 1 |
| 180 Life Sciences Corp. | 2025-07-24 | Approval of the adoption of the Fourth Amendment to the 180 Life Sciences Corp. 2022 Omnibus Incentive Plan | Compensation | Board | AGAINST | 1 |
| 180 Life Sciences Corp. | 2025-07-24 | Election of Directors: Lawrence Steinman, M.D. | Director Elections | Board | ABSTAIN | 1 |
| 3D Systems Corporation | 2026-05-14 | The approval of the amendment and restatement of the 2015 Incentive Plan to increase the number of shares reserved for issuance thereunder by 4,000,000 shares and to extend the term until 2036. | Compensation | Board | AGAINST | 1 |
| 8x8, Inc. | 2025-07-25 | To approve an amendment to the 8x8, Inc.'s 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 8,500,000 shares. | Compensation | Board | AGAINST | 1 |
| A10 Networks, Inc. | 2026-04-22 | To approve, on an advisory and non-binding basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 |
| ACV Auctions Inc. | 2026-05-27 | Elect the two Class II directors named in this Proxy Statement: Eileen Kamerick | Director Elections | Board | ABSTAIN | 1 |
| ADC Therapeutics SA | 2026-06-01 | Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company's capital range (article 4a), conditional share capital for employee participation (article 4b) and conditional share capital for financing, acquisitions and other purposes (article 4c) as well as the introduction of article 4d regarding a conditional share capital based on the capital range. The Board of Directors proposes that the amendments to article 4a paragraph 1 of the articles of association to increase the Company's capital range from CHF 8,375,974.48 (lower limit) and CHF 12,354,128.80 (upper limit) to CHF 10,378,109.12 (lower limit) and CHF 15,567,163.68 (upper limit) be approved. | Capital Structure | Board | AGAINST | 1 |
| ADC Therapeutics SA | 2026-06-01 | Approving an amendment to increase the number of shares authorized under the 2019 Equity Incentive Plan The Board of Directors proposes that an amendment to increase the number of shares authorized under 2019 Equity Incentive Plan be approved. | Compensation | Board | AGAINST | 1 |
| ADC Therapeutics SA | 2026-06-01 | Approving, on a binding basis under Swiss law, the compensation of the Board of Directors and the Executive Committee The Board of Directors proposes that the maximum aggregate amount of compensation for the members of the Board of Directors for the period between the Annual Meeting and the 2027 annual general meeting of Shareholders be set at $2,500,000. | Compensation | Board | AGAINST | 1 |
| ADC Therapeutics SA | 2026-06-01 | The Board of Directors proposes that a new article 4d be introduced in the articles of association regarding a conditional share capital based on the capital range, and that article 4a be amended accordingly, to provide for the issuance of up to 64,863,182 common shares (CHF 5,189,054.56). | Capital Structure | Board | AGAINST | 1 |
| ADC Therapeutics SA | 2026-06-01 | The Board of Directors proposes that the amendments to article 4b paragraph 1 of the articles of association to increase the Company's conditional share capital for employee participation from 9,887,629 common shares (CHF 791,010.32) to 16,836,253 common shares (CHF 1,346,900.24) be approved. | Capital Structure | Board | AGAINST | 1 |
| ADC Therapeutics SA | 2026-06-01 | The Board of Directors proposes that the amendments to article 4c paragraph 1 of the articles of association to increase the Company's conditional share capital for financing, acquisitions and other purposes from 38,026,929 common shares (CHF 3,042,154.32) to 48,026,929 common shares (CHF 3,842,154.32) be approved. | Capital Structure | Board | AGAINST | 1 |
| ADT Inc. | 2026-05-27 | Election of Directors To be elected for terms expiring in 2027: Danielle Tiedt | Director Elections | Board | ABSTAIN | 1 |
| ALX Oncology Holdings Inc. | 2026-06-10 | Election of Directors: Rekha Hemrajani | Director Elections | Board | ABSTAIN | 1 |
| AMC Global Media Inc. | 2026-06-16 | Advisory vote on Named Executive Officer compensation | Say-on-Pay | Board | AGAINST | 1 |
| AMC Global Media Inc. | 2026-06-16 | Election of the following nominees as Directors: Carl E. Vogel | Director Elections | Board | ABSTAIN | 1 |
| AMC Global Media Inc. | 2026-06-16 | Election of the following nominees as Directors: Debra G. Perelman | Director Elections | Board | ABSTAIN | 1 |
| AMC Global Media Inc. | 2026-06-16 | Election of the following nominees as Directors: Matthew C. Blank | Director Elections | Board | ABSTAIN | 1 |
| Absci Corporation | 2026-06-04 | The election of the Class II directors nominated by the Board of Directors and named in our Proxy Statement to hold office for a three-year term expiring at our 2029 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified: Prof Sir Menelas Pangalos, Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Aclaris Therapeutics, Inc. | 2026-06-04 | Election of Directors: Anand Mehra, M.D. | Director Elections | Board | ABSTAIN | 1 |
| Aclaris Therapeutics, Inc. | 2026-06-04 | Election of Directors: Maxine Gowen, Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Aclaris Therapeutics, Inc. | 2026-06-04 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. | Say-on-Pay | Board | AGAINST | 1 |
| Acrivon Therapeutics, Inc. | 2026-06-17 | Election of Class I directors: Charles Baum, M.D., Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Acrivon Therapeutics, Inc. | 2026-06-17 | To approve an amendment and restatement of the Company's 2022 Equity Incentive Plan to, among other things, increase the number of shares authorized for issuance thereunder. | Compensation | Board | AGAINST | 1 |
| Acumen Pharmaceuticals, Inc. | 2026-06-03 | To approve the Company's Amended and Restated 2021 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 |
| Acumen Pharmaceuticals, Inc. | 2026-06-03 | To elect three Class II directors to the Board of Directors, each to hold office until the 2029 Annual Meeting of Stockholders, and until his or her successor shall have been duly elected and qualified: George Golumbeski, Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Acushnet Holdings Corp. | 2026-06-08 | Election of the following nominees for director: David Maher | Director Elections | Board | ABSTAIN | 1 |
| Acushnet Holdings Corp. | 2026-06-08 | Election of the following nominees for director: Ho Yeon (Aaron) Lee | Director Elections | Board | ABSTAIN | 1 |
| Acushnet Holdings Corp. | 2026-06-08 | Election of the following nominees for director: Keun Chang (Kevin) Yoon | Director Elections | Board | ABSTAIN | 1 |
| Acushnet Holdings Corp. | 2026-06-08 | Election of the following nominees for director: Yoon Soo (Gene) Yoon | Director Elections | Board | ABSTAIN | 1 |
| Adecoagro SA | 2026-04-15 | Reelect Andres Larriera as Director | Director Elections | Board | AGAINST | 1 |
| Adecoagro SA | 2026-04-15 | Reelect Oscar Leon Bentancor as Director | Director Elections | Board | AGAINST | 1 |
| Adobe Inc. | 2026-04-15 | Approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 |
| AerCap Holdings NV | 2026-04-15 | Approve Increase in Number of Ordinary Shares for Issuance under the Equity Incentive Plan | Compensation | Board | AGAINST | 1 |
| AerCap Holdings NV | 2026-04-15 | Approve Report of the Nomination and Compensation Committee | Compensation | Board | AGAINST | 1 |
| AerSale Corporation | 2026-06-11 | Approval of the redomestication of the Company from Delaware to Texas by conversion. | Extraordinary Transactions | Board | AGAINST | 1 |
| AerSale Corporation | 2026-06-11 | Approval, on an advisory basis, of the Company's named executive officer compensation. | Say-on-Pay | Board | AGAINST | 1 |
| Agenus Inc. | 2026-06-16 | To approve a one-time stock option exchange program under our 2019 EIP, our Amended and Restated 2009 Equity Incentive Plan, and our 2015 Inducement Equity Plan, with premium strike prices applicable to director and executive officer replacement options. | Compensation | Board | AGAINST | 1 |
| Agenus Inc. | 2026-06-16 | To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan to increase the aggregate shares available for issuance by 5,000,000 shares. | Compensation | Board | AGAINST | 1 |
| Agenus Inc. | 2026-06-16 | To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers for 2025 (Say-on-Pay). | Say-on-Pay | Board | AGAINST | 1 |
| Agenus Inc. | 2026-06-16 | To elect Garo Armen and Jennifer Buell as Class II directors, for a term of three years expiring at the 2029 Annual Meeting of Stockholders.: Garo Armen | Director Elections | Board | ABSTAIN | 1 |
| AgriFORCE Growing Systems Ltd. | 2025-10-27 | Approval of an amendment to the 2024 equity incentive plan to increase the number of shares reserved for issuance from 87,237 to 5,750,000. | Compensation | Board | AGAINST | 1 |
| Airbnb, Inc. | 2026-06-05 | To elect Nathan Blecharczyk, Alfred Lin and James Manyika as Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: Nathan Blecharczyk | Director Elections | Board | ABSTAIN | 1 |
| Akamai Technologies, Inc. | 2026-05-13 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. | Compensation | Board | AGAINST | 1 |
| Akamai Technologies, Inc. | 2026-05-13 | To vote upon a shareholder proposal requiring the Company to provide a report on political spending. | Other Social Issues | Shareholder | FOR | 1 |
| Akanda Corp. | 2025-08-29 | Amend Articles of Incorporation to Authorize New Classes of Special Common Stock and New Class of Blank Check Preferred Stock | Capital Structure | Board | AGAINST | 1 |
| Alarum Technologies Ltd. | 2025-08-07 | Approve Grant of RSUs to Shachar Daniel, CEO and Director | Compensation | Board | AGAINST | 1 |
| Alector, Inc. | 2026-06-17 | ELECTION OF DIRECTORS: Kristine Yaffe, M.D. | Director Elections | Board | ABSTAIN | 1 |
| Algorhythm Holdings, Inc. | 2025-11-20 | To approve an amendment to the Company's 2022 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder to 5,000,000. | Compensation | Board | AGAINST | 1 |
| Alight, Inc. | 2026-06-10 | To elect three Class II director nominees named in the proxy statement to our Board of Directors (the "Board"): Russell P. Fradin | Director Elections | Board | ABSTAIN | 1 |
| Allogene Therapeutics, Inc. | 2026-06-18 | Election of Directors: Deborah Messemer | Director Elections | Board | ABSTAIN | 1 |
| Allogene Therapeutics, Inc. | 2026-06-18 | Election of Directors: Owen Witte, M.D. | Director Elections | Board | ABSTAIN | 1 |
| Allogene Therapeutics, Inc. | 2026-06-18 | Election of Directors: Vicki Sato, Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Alphabet Inc. | 2026-06-05 | Advisory vote to approve compensation awarded to named executive officers | Say-on-Pay | Board | AGAINST | 1 |
| Alphabet Inc. | 2026-06-05 | Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stock | Compensation | Board | AGAINST | 1 |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: Frances H. Arnold | Director Elections | Board | AGAINST | 1 |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: John L. Hennessy | Director Elections | Board | AGAINST | 1 |
| Alphabet Inc. | 2026-06-05 | Shareholder proposal regarding a report on AI data usage oversight | Other Social Issues | Shareholder | FOR | 1 |
| Alphatec Holdings, Inc. | 2026-06-10 | To approve the Alphatec Holdings, Inc. 2026 Equity Incentive Plan; | Compensation | Board | AGAINST | 1 |
| Altimmune, Inc. | 2025-09-25 | Hold an advisory vote on compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. | Say-on-Pay | Board | AGAINST | 1 |
| Alto Neuroscience, Inc. | 2026-05-12 | To approve an amendment and restatement of the Company's 2024 Employee Stock Purchase Plan to treat outstanding pre-funded warrants the same as outstanding shares of Common Stock for purposes of calculating the number of shares to be automatically added to the share reserve thereunder pursuant to the "evergreen" feature of the 2024 Employee Stock Purchase Plan. | Compensation | Board | AGAINST | 1 |
| Alto Neuroscience, Inc. | 2026-05-12 | To approve an amendment and restatement of the Company's 2024 Equity Incentive Plan to treat outstanding pre-funded warrants the same as outstanding shares of Common Stock for purposes of calculating the number of shares to be automatically added to the share reserve thereunder pursuant to the "evergreen" feature of the 2024 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 |
| Amentum Holdings, Inc. | 2026-02-06 | Election of Directors: Barbara L. Loughran | Director Elections | Board | AGAINST | 1 |
| Amerant Bancorp Inc. | 2026-06-02 | To elect the directors to serve until the 2027 annual meeting of shareholders: Millar Wilson | Director Elections | Board | AGAINST | 1 |
| American Assets Trust, Inc. | 2026-06-01 | Election of Directors: Dr. Robert S. Sullivan | Director Elections | Board | ABSTAIN | 1 |
| American Assets Trust, Inc. | 2026-06-01 | Election of Directors: Joy L. Schaefer | Director Elections | Board | ABSTAIN | 1 |
| American Integrity Insurance Group, Inc. | 2026-06-11 | To elect one Class I director to serve until the Company's 2029 annual meeting of stockholders and until such director's successor shall have been duly elected and qualified or until such director's earlier death, resignation or removal: Steven Smathers | Director Elections | Board | AGAINST | 1 |
| American Resources Corporation | 2026-04-15 | ELECTION OF DIRECTORS: Courtenay O. Taplin | Director Elections | Board | ABSTAIN | 1 |
| American Resources Corporation | 2026-04-15 | ELECTION OF DIRECTORS: D. Joshua Hawes | Director Elections | Board | ABSTAIN | 1 |
| American Resources Corporation | 2026-04-15 | ELECTION OF DIRECTORS: Dr. Gerardine G. Botte | Director Elections | Board | ABSTAIN | 1 |
| American Resources Corporation | 2026-04-15 | ELECTION OF DIRECTORS: Mark J. LaVerghetta | Director Elections | Board | ABSTAIN | 1 |
| American Well Corporation | 2026-06-16 | To elect two Class III directors to serve until the 2029 annual meeting of stockholders: Dr. Ido Schoenberg | Director Elections | Board | ABSTAIN | 1 |
| Americas Gold and Silver Corporation | 2026-06-23 | Elect Director Peter Goudie | Director Elections | Board | ABSTAIN | 1 |
| Amplitude, Inc. | 2026-06-09 | The election of three Class II directors to hold office until the 2029 Annual Meeting of Stockholders, and until each such director's respective successor is elected and qualified: Pat Grady | Director Elections | Board | ABSTAIN | 1 |
| Amprius Technologies, Inc. | 2026-06-11 | Election of Class I Directors: Kathleen Bayless | Director Elections | Board | ABSTAIN | 1 |
| Amprius Technologies, Inc. | 2026-06-11 | Election of Class I Directors: Thomas M. Stepien | Director Elections | Board | ABSTAIN | 1 |
| Amrize Ltd. | 2026-04-21 | Re-election of Jan Jenisch as Chairman of the Board | Director Elections | Board | AGAINST | 1 |
| Amtech Systems, Inc. | 2026-03-04 | Election of Directors: Asif Jakwani | Director Elections | Board | ABSTAIN | 1 |
| Amtech Systems, Inc. | 2026-03-04 | Election of Directors: Michael Garnreiter | Director Elections | Board | ABSTAIN | 1 |
| Amtech Systems, Inc. | 2026-03-04 | Election of Directors: Michael M. Ludwig | Director Elections | Board | ABSTAIN | 1 |
| Amtech Systems, Inc. | 2026-03-04 | Election of Directors: Robert M. Averick | Director Elections | Board | ABSTAIN | 1 |
| Amtech Systems, Inc. | 2026-03-04 | To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the accompanying proxy statement. | Say-on-Pay | Board | AGAINST | 1 |
| Amylyx Pharmaceuticals, Inc. | 2026-06-04 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 |
| Annovis Bio, Inc. | 2026-06-17 | ELECTION OF DIRECTORS: Claudine Bruck | Director Elections | Board | ABSTAIN | 1 |
| Annovis Bio, Inc. | 2026-06-17 | ELECTION OF DIRECTORS: Mark White | Director Elections | Board | ABSTAIN | 1 |
| Annovis Bio, Inc. | 2026-06-17 | ELECTION OF DIRECTORS: Michael Hoffman | Director Elections | Board | ABSTAIN | 1 |
| Annovis Bio, Inc. | 2026-06-17 | ELECTION OF DIRECTORS: Reid McCarthy | Director Elections | Board | ABSTAIN | 1 |
| Annovis Bio, Inc. | 2026-06-17 | To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 | Audit-related | Board | AGAINST | 1 |
| Apollo Global Management, Inc. | 2026-06-08 | An advisory vote to approve the compensation of AGM's named executive officers (Say on Pay); | Say-on-Pay | Board | AGAINST | 1 |
| AppLovin Corporation | 2026-06-03 | Approval, on an advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 |
| AppLovin Corporation | 2026-06-03 | Election of Directors: ADAM FOROUGHI | Director Elections | Board | ABSTAIN | 1 |
| AppLovin Corporation | 2026-06-03 | Election of Directors: BARBARA MESSING | Director Elections | Board | ABSTAIN | 1 |
| AppLovin Corporation | 2026-06-03 | Election of Directors: EDUARDO VIVAS | Director Elections | Board | ABSTAIN | 1 |
| AppLovin Corporation | 2026-06-03 | Election of Directors: HERALD CHEN | Director Elections | Board | ABSTAIN | 1 |
| AppLovin Corporation | 2026-06-03 | Election of Directors: MARGARET GEORGIADIS | Director Elections | Board | ABSTAIN | 1 |
| AppLovin Corporation | 2026-06-03 | Election of Directors: MAYNARD WEBB | Director Elections | Board | ABSTAIN | 1 |
| Appian Corporation | 2026-06-03 | Election of Directors: Barbara Bobbie Kilberg | Director Elections | Board | ABSTAIN | 1 |
| Appian Corporation | 2026-06-03 | Election of Directors: Mark Lynch | Director Elections | Board | ABSTAIN | 1 |
Page 1 of 14 Next →
← Back to Blackstone Alternative Investment Funds 2025-2026 overview
Built 2026-09-27 from SEC Form N-PX filings.